Cargando…

Trends in Out-of-Pocket Costs for and Characteristics of Pharmacy-Dispensed Buprenorphine Medications for Opioid Use Disorder Treatment by Type of Payer, 2015 to 2020

IMPORTANCE: Buprenorphine has been approved for opioid use disorder treatment, yet remains underutilized. Cost may present a barrier; little is known about how out-of-pocket costs vary. OBJECTIVE: To determine if out-of-pocket costs and prescription characteristics for buprenorphine varied by type o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strahan, Andrea E., Desai, Shaina, Zhang, Kun, Guy, Gery P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918874/ https://www.ncbi.nlm.nih.gov/pubmed/36763363 http://dx.doi.org/10.1001/jamanetworkopen.2022.54590

Ejemplares similares

Trends in Out-of-Pocket Costs for Naloxone by Drug Brand and Payer in the US, 2010-2018
por: Peet, Evan D., et al.
Publicado: (2022)

Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex – United States, March 2019 – December 2020
por: Cremer, Laura J., et al.
Publicado: (2022)

State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain
por: Lyu, Xiru, et al.
Publicado: (2023)

Prescribed Opioid Dosages, Payer Type, and Self-Reported Outcomes After Surgical Procedures in Michigan, 2018-2020
por: Breuler, Christopher J., et al.
Publicado: (2023)

Trends in Opioid Prescribing and Dispensing by Veterinarians in Pennsylvania
por: Clarke, Dana L., et al.
Publicado: (2019)

Assessment of Out-of-Pocket Spending for COVID-19 Hospitalizations in the US in 2020
por: Chua, Kao-Ping, et al.
Publicado: (2021)

Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees
por: Wen, Hefei, et al.
Publicado: (2018)

Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
por: Weiner, Scott G., et al.
Publicado: (2023)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio
por: Molfenter, Todd, et al.
Publicado: (2015)

Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper
por: Bozinoff, Nikki, et al.
Publicado: (2022)

Buprenorphine Dispensing in Pennsylvania During the COVID-19 Pandemic, January to October 2020
por: Chalasani, Rohan, et al.
Publicado: (2021)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

Lower buprenorphine elimination rate constant is associated with lower opioid use
por: Elarabi, Hesham Farouk, et al.
Publicado: (2022)

Opioid replacement therapy with methadone or buprenorphine effects on male mice reproduction
por: Moinaddini, Fatemeh, et al.
Publicado: (2022)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Comparing actual and forecasted numbers of unique patients dispensed select medications for opioid use disorder, opioid overdose reversal, and mental health, during the COVID-19 pandemic, United States, January 2019 to May 2020
por: Jones, Christopher M., et al.
Publicado: (2021)

Trends in Out-of-Pocket Cost of Glucagon, 2010-2020
por: Zupa, Margaret, et al.
Publicado: (2022)

Vital Signs: Pharmacy-Based Naloxone Dispensing — United States, 2012–2018
por: Guy, Gery P., et al.
Publicado: (2019)

Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes
por: Taylor, Erin A., et al.
Publicado: (2023)

Factors in rural community buprenorphine dispensing
por: Major, Erin G., et al.
Publicado: (2022)

High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
por: Herring, Andrew A., et al.
Publicado: (2021)

Implementation Facilitation to Promote Emergency Department–Initiated Buprenorphine for Opioid Use Disorder
por: D’Onofrio, Gail, et al.
Publicado: (2023)

Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees
por: Hammerslag, Lindsey R., et al.
Publicado: (2023)

Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder
por: Christine, Paul J., et al.
Publicado: (2023)

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-of-Pocket Costs
por: Rome, Benjamin N., et al.
Publicado: (2021)

Association of Out-of-Pocket Pharmacy Costs with Adherence to Varenicline
por: Suehs, Brandon T., et al.
Publicado: (2014)

Trends in dispensing of individual prescription opioid formulations, Canada 2005–2020
por: Jones, Wayne, et al.
Publicado: (2022)

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail
por: Lee, Joshua D., et al.
Publicado: (2021)

Association of 3 CDC opioid prescription guidelines for chronic pain and 2 payer pharmacy coverage changes on opioid initiation practices
por: Togun, Adeniyi T, et al.
Publicado: (2021)

Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use
por: Xu, Kevin Y., et al.
Publicado: (2022)

Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
por: Chambers, Laura C., et al.
Publicado: (2023)

Variation in Adult Outpatient Opioid Prescription Dispensing by Age and Sex — United States, 2008–2018
por: Schieber, Lyna Z., et al.
Publicado: (2020)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Association between county-level sociodemographic characteristics and county-level differences in opioid dispensing
por: Cremer, Laura J., et al.
Publicado: (2021)

Changes in Initial Opioid Prescribing Practices After the 2016 Release of the CDC Guideline for Prescribing Opioids for Chronic Pain
por: Goldstick, Jason E., et al.
Publicado: (2021)

Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017
por: Schieber, Lyna Z., et al.
Publicado: (2019)

Implementation of a Pharmacy Follow-Up Program for Dispensed Opioid Medications
por: Skoy, Elizabeth, et al.
Publicado: (2023)

Buprenorphine Use Trends Following Removal of Prior Authorization Policies for the Treatment of Opioid Use Disorder in 2 State Medicaid Programs
por: Keshwani, Shailina, et al.
Publicado: (2022)

All-payer ratesetting: Down but not out
por: Anderson, Gerard F.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_3hulgnpohek8akneui23hd0ia3